MDXH
MDxHealth S.A.
NASDAQ · Healthcare · Medical - Diagnostics & Research · BE
$0.75
+3.06%Year over year
Reported trailing growth
- Revenue
- +59.7%
- EBITDA
- +68.4%
- EBIT
- +41.4%
- EPS
- +63.0%
- Free cash flow
- +65.5%
- Operating cash flow
- +64.5%
Forward estimates
Based on analyst estimates
- Revenue
- -23.8%
- EBITDA
- +267.8%
- EPS
- +89.3%
Three-year CAGR
- Revenue
- +42.8%
- EBITDA
- +36.4%
- EBIT
- +37.7%
- Net income
- +12.0%
- EPS
- +14.1%
- Free cash flow
- +44.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025